NASDAQ: LYRA
Lyra Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their LYRA stock forecasts and price targets.

Forecast return on equity

Is LYRA forecast to generate an efficient return?

Company
-69.84%
Industry
150.94%
Market
92.3%
LYRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LYRA forecast to generate an efficient return on assets?

Company
-18.29%
Industry
34.96%
LYRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LYRA earnings per share forecast

What is LYRA's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.58
Avg 2 year Forecast
-$0.83
Avg 3 year Forecast
-$0.59

LYRA revenue forecast

What is LYRA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.2M-18.08%
Avg 2 year Forecast
$11.3M+668.18%
Avg 3 year Forecast
$35.5M+2,309.93%
LYRA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LYRA revenue growth forecast

How is LYRA forecast to perform vs Biotechnology companies and vs the US market?

Company
181.73%
Industry
50.16%
Market
11.79%
LYRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LYRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LYRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LYRA$0.21N/AN/A
NERV$1.97$5.00+153.81%Hold
PYPD$2.95$10.50+255.93%Buy
IMNN$0.90$20.50+2,177.78%Strong Buy
BCDA$2.84$25.00+780.28%Buy

Lyra Therapeutics Stock Forecast FAQ

What is LYRA's earnings growth forecast for 2025-2027?

(NASDAQ: LYRA) Lyra Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.91%.

Lyra Therapeutics's earnings in 2025 is -$97,612,000.On average, 3 Wall Street analysts forecast LYRA's earnings for 2025 to be -$37,965,436, with the lowest LYRA earnings forecast at -$56,293,577, and the highest LYRA earnings forecast at -$23,564,753. On average, 1 Wall Street analyst forecast LYRA's earnings for 2026 to be -$54,329,848, with the lowest LYRA earnings forecast at -$54,329,848, and the highest LYRA earnings forecast at -$54,329,848.

In 2027, LYRA is forecast to generate -$38,620,012 in earnings, with the lowest earnings forecast at -$38,620,012 and the highest earnings forecast at -$38,620,012.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

What is LYRA's revenue growth forecast for 2025-2027?

(NASDAQ: LYRA) Lyra Therapeutics's forecast annual revenue growth rate of 181.73% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.79%.

Lyra Therapeutics's revenue in 2025 is $1,471,000.On average, 2 Wall Street analysts forecast LYRA's revenue for 2025 to be $78,876,466, with the lowest LYRA revenue forecast at $53,675,271, and the highest LYRA revenue forecast at $104,077,660. On average, 1 Wall Street analysts forecast LYRA's revenue for 2026 to be $739,671,422, with the lowest LYRA revenue forecast at $739,671,422, and the highest LYRA revenue forecast at $739,671,422.

In 2027, LYRA is forecast to generate $2,320,473,622 in revenue, with the lowest revenue forecast at $2,320,473,622 and the highest revenue forecast at $2,320,473,622.

What is LYRA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: LYRA) forecast ROA is -18.29%, which is lower than the forecast US Biotechnology industry average of 34.96%.

What is LYRA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: LYRA) Lyra Therapeutics's current Earnings Per Share (EPS) is -$1.49. On average, analysts forecast that LYRA's EPS will be -$0.58 for 2025, with the lowest EPS forecast at -$0.86, and the highest EPS forecast at -$0.36. On average, analysts forecast that LYRA's EPS will be -$0.83 for 2026, with the lowest EPS forecast at -$0.83, and the highest EPS forecast at -$0.83. In 2027, LYRA's EPS is forecast to hit -$0.59 (min: -$0.59, max: -$0.59).

What is LYRA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: LYRA) forecast ROE is -69.84%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.